Literature DB >> 26617659

Takotsubo Cardiomyopathy related to Pheochromocytoma or Other Etiology Should Be Considered as Similar.

Sébastien Champion1.   

Abstract

Entities:  

Year:  2015        PMID: 26617659      PMCID: PMC4661372          DOI: 10.4070/kcj.2015.45.6.535

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


× No keyword cloud information.
To the Editor: Choi et al.1) compared 20 patients with definite pheochromocytoma and various cardiac manifestations to 20 controls with Takotsubo after intense emotional stress. However, the usual diagnostic criterion for Takotsubo cardiomyopathy is self-improvement and (complete or near complete) correction of motion abnormalities. Did the patients have to demonstrate this correction to be included in the Takotsubo group? Furthermore, the inclusion of only 20 patients in the control group during the relatively long retrospective study lasting from 2002 to 2013 is unusual. Accordingly, Takotsubo cardiomyopathy is frequently compared to pheochromocytoma. Was there an attempt to pair both groups? Additionally, I would like to know how many patients with pheochromocytoma eventually exhibited atypical Takotsubo echocardiographic patterns. However, my main concern is that I think they compared two groups with similar diseases, despite a few differences in QT and left ventricular mass measurements. Pheochromocytoma and intense emotional stress share a surge in catecholamines as the main mechanism for Takotsubo induction.2) Consequently, one should be careful when comparing Takotsubo following epinephrine injection, emotional stress, bronchodilator inhalation, and extreme dyspnea. Entangled mechanisms leading to Takotsubo cardiomyopathy have already been acknowledged.2) Indeed, much effort is needed to determine the diagnostic criteria differentiating Takotsubo from acute anterior myocardial infarction in order to prevent invasive coronary angiography involving iodine products and potentially deleterious pharmacological treatments. This should include electrocardiograms (with electrical alternance and QT prolongation), echocardiography (symmetric wall motion anomaly, right ventricular impairment), biological index (minimal troponin release compared to the extent of myocardial akinesis), cardiac magnetic resonance (valuable accuracy but difficult to perform urgently in unstable patients),3) and obviously clinical findings.
  3 in total

1.  Stress (Tako-tsubo) cardiomyopathy in critically-ill patients.

Authors:  Sébastien Champion; Dominique Belcour; David Vandroux; Didier Drouet; Bernard A Gaüzère; Bruno Bouchet; Guillaume Bossard; Sabina Djouhri; Julien Jabot; Mathilde Champion; Yannick Lefort
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2014-09-08

Review 2.  Usefulness of MRI in takotsubo cardiomyopathy: a review of the literature.

Authors:  Andres Alejandro Kohan; Ezequiel Levy Yeyati; Luciano De Stefano; Laura Dragonetti; Marcelo Pietrani; Diego Perez de Arenaza; Cesar Belziti; Ricardo Daniel García-Mónaco
Journal:  Cardiovasc Diagn Ther       Date:  2014-04

3.  Impact of Pheochromocytoma on Left Ventricular Hypertrophy and QTc Prolongation: Comparison with Takotsubo Cardiomyopathy.

Authors:  Seon Yoon Choi; Kyoung Im Cho; You Jin Han; Ga In You; Je Hun Kim; Jeong Ho Heo; Hyun Soo Kim; Tae Joon Cha; Jae Woo Lee
Journal:  Korean Circ J       Date:  2014-03-12       Impact factor: 3.243

  3 in total
  1 in total

1.  Pheochromocytoma as a cause of repeated acute myocardial infarctions, heart failure, and transient erythrocytosis: A case report and review of the literature.

Authors:  Fei Shi; Li-Xian Sun; Sen Long; Ying Zhang
Journal:  World J Clin Cases       Date:  2021-02-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.